Suchergebnisse - "Holstein, Sarah A"

PubPharm (187)

1

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

2

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

3

α-Amino bisphosphonate triazoles serve as GGDPS inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Gehrke, N. | Feng, D. | Ayub Ali, M. | +3

4

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

5

Investigation of the activity of a novel tropolone in osteosarcoma

enthalten in: Drug development research | 2024

von Haney, S. | Feng, D. | Kollala, S. | +6

6

Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia

enthalten in: Journal of geriatric oncology | 2024

von Bhatt, V. | Wichman, C. | Koll, T. | +7

7

Structural Insight into Geranylgeranyl Diphosphate Synthase (GGDPS) for Cancer Therapy

enthalten in: Molecular cancer therapeutics | 2024

von Pham, A. | Holstein, S. | Borgstahl, G.

8

Investigation of the activity of a novel tropolone in osteosarcoma

enthalten in: Drug Development Research | 2024

von Haney, S. | Feng, D. | Kollala, S. | +6

9

Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN) : final analysis of an open-label, randomised, phase 2 trial

enthalten in: The Lancet. Haematology | 2023

von Voorhees, P. | Sborov, D. | Laubach, J. | +25

CommentIn: Lancet Haematol. 2023 Oct;10(10):e788-e789. - PMID 37793762

10

Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma : Moving Into the Future

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Holstein, S. | Grant, S. | Wildes, T.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]